Provided by Tiger Trade Technology Pte. Ltd.

Septerna, Inc.

38.15
-0.7600-1.95%
Volume:415.35K
Turnover:15.86M
Market Cap:1.78B
PE:-70.33
High:39.11
Open:38.71
Low:37.39
Close:38.91
52wk High:51.10
52wk Low:11.98
Shares:46.68M
Float Shares:22.90M
Volume Ratio:1.24
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5424
EPS(LYR):-1.1044
ROE:-6.34%
ROA:-7.13%
PB:4.60
PE(LYR):-34.54

Loading ...

Press Release: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 11

Septerna SVP Drug Discovery Daniel D. Long Sells USD 114,901.29 in Common Shares

Reuters
·
Aug 06

3 Small-Cap Stocks Analysts Expect to Rally Big

TIPRANKS
·
Aug 04

3 Small-Cap Stocks with ‘Strong Buy’ Ratings and 40%+ Upside, According to Analysts

TIPRANKS
·
Jul 20

Septerna President and COO Elizabeth Bhatt Sells 4,000 Shares for $135,974

Reuters
·
Jul 18

Is Septerna (SEPN) Fully Valued Following Its Russell Index Inclusions?

Simply Wall St.
·
Jul 11

Septerna SVP Drug Discovery Daniel D. Long Disposes of 3,333 Common Shares Worth $113,104.20

Reuters
·
Jul 03

Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating

MT Newswires Live
·
Jul 01

Septerna Price Target Maintained with a $40.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 01

Septerna is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 01

Septerna price target raised to $43 from $35 at Truist

TIPRANKS
·
Jul 01

Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR)

TIPRANKS
·
Jul 01

Septerna price target lowered to $45 from $52 at Guggenheim

TIPRANKS
·
Jul 01

Septerna Buy Rating Reiterated as Analyst Sees Favorable Risk‑Reward and Keeps $40 Price Target Unchanged

TIPRANKS
·
Jul 01

Septerna Chief People Officer Samira Shaikhly Disposes of 2,178 Common Shares for $76,638.24

Reuters
·
Jul 01

Septerna Holds Annual Shareholder Meeting

Reuters
·
Jul 01

Cantor Fitzgerald Reaffirms Their Buy Rating on Septerna, Inc. (SEPN)

TIPRANKS
·
Jun 30

Septerna SVP Drug Discovery Daniel D. Long Disposes of 15,000 Common Shares Worth $548,782

Reuters
·
Jun 25

Is Guggenheim’s New Coverage of Septerna (SEPN) Reframing the Story Around Operating Efficiency?

Simply Wall St.
·
Jun 18

Wells Fargo Keeps Their Buy Rating on Septerna, Inc. (SEPN)

TIPRANKS
·
Jun 17